MFS Growth R6

MFS Growth R6 Fund · US5529856735 · MFEKX (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MFS Growth R6
No Price
01.05.2026 12:06
Current Prices from MFS Growth R6
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MFEKX
USD
01.05.2026 12:06
201,65 USD
0,33 USD
+0,16 %
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 184,58 M
Company Profile for MFS Growth R6 Fund
The fund normally invests the fund’s assets primarily in equity securities. Equity securities include common stocks and other securities that represent an ownership interest (or right to acquire an ownership interest) in a company or other issuer. The adviser focuses on investing the fund's assets in the stocks of companies the advisor believes to have above average earnings growth potential compared to other companies (growth companies).

Company Data

Name MFS Growth R6
Company MFS Growth R6
Symbol MFEKX
Primary Exchange XNAS NASDAQ
ISIN US5529856735
Asset Class Fund
Market Capitalization 37 Mrd.
Country United States of America
Currency USD
Employees -
Address Boston, MA 2199, 2199 Boston
IPO Date 2011-08-26
Dividends from 'MFS Growth R6'
Ex-Date Dividend per Share
16.12.2025 25,35 USD
31.07.2025 4,13 USD
17.12.2024 51,01 USD
31.07.2024 0,52 USD
19.12.2023 7,91 USD
31.07.2023 0,45 USD
13.12.2022 1,39 USD
14.12.2021 4,65 USD
30.06.2021 0,72 USD
15.12.2020 5,45 USD

Ticker Symbols

Name Symbol
NASDAQ MFEKX
More Shares
Investors who hold MFS Growth R6 also have the following shares in their portfolio:
KARYOPHARM THERAPEUTICSCS INC
KARYOPHARM THERAPEUTICSCS INC Share
Oxford Lane Capital Corp. - 7.125% Series 2029 Term Preferred Stock
Oxford Lane Capital Corp. - 7.125% Series 2029 Term Preferred Stock Share